Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population.

Health Related Quality of Life allergic rhinitis questionnaire validation study

Journal

Postepy dermatologii i alergologii
ISSN: 1642-395X
Titre abrégé: Postepy Dermatol Alergol
Pays: Poland
ID NLM: 101168357

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 18 04 2019
accepted: 29 05 2019
entrez: 30 5 2020
pubmed: 30 5 2020
medline: 30 5 2020
Statut: ppublish

Résumé

The RhinAsthma Patient Perspective (RAPP) was developed in Italian to assess the Health Related Quality of Life (HRQoL) impairment in patients with asthma and allergic rhinitis (AR) in daily practice. To cross-culturally validate the Polish version. The Polish version was administered to patients suffering from asthma and rhinitis in a prospective observational study. Polish RAPP, along with SF-12, ACT, and a Symptomatologic VAS was filled in twice, with a 4-week interval between visits. At visit 2, a Global Rating Scale (GRS) was completed to assess any change in health status. Internal consistency, validity, reliability, discriminant ability and responsiveness to change as well as Minimal Important Difference were determined. The factor and confirmatory analysis revealed a unidimensional structure of RAPP. Internal consistency was satisfactory with Cronbach's α (visit 1 = 0.85, visit 2 = 0.89). High reliability (ICC = 0.89 and a CCC = 0.94) was found. Validity analyses showed good correlations of the Polish RAPP with Physical and Mental Component Scores of SF-12. In addition, RAPP adequately discriminated patients on the basis of the asthma control level and rhinitis severity ( The study confirmed the reliability and validity of the Polish version of RAPP demonstrating that it is a useful tool in the assessment of HRQoL in patients with asthma and comorbid allergic rhinitis, in clinical practice.

Identifiants

pubmed: 32467692
doi: 10.5114/ada.2020.93387
pii: 93387
pmc: PMC7247060
doi:

Types de publication

Journal Article

Langues

eng

Pagination

97-102

Informations de copyright

Copyright: © 2020 Termedia Sp. z o. o.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Qual Life Res. 2002 May;11(3):193-205
pubmed: 12074258
J Allergy Clin Immunol. 2004 Jan;113(1):59-65
pubmed: 14713908
Allergy. 2007 Apr;62(4):367-72
pubmed: 17362246
J Clin Epidemiol. 2015 Sep;68(9):1085-92
pubmed: 25962972
J Am Med Inform Assoc. 2017 Sep 1;24(5):964-968
pubmed: 28339771
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Patient Relat Outcome Meas. 2018 Aug 17;9:267-273
pubmed: 30147386
Health Qual Life Outcomes. 2017 Sep 29;15(1):189
pubmed: 28962623
J Patient Rep Outcomes. 2018 Aug 17;2:34
pubmed: 30175316
Respir Med. 2018 Aug;141:198-206
pubmed: 30053967
J Clin Epidemiol. 2009 Apr;62(4):374-9
pubmed: 19013766
Biometrics. 1989 Mar;45(1):255-68
pubmed: 2720055
Wien Klin Wochenschr. 2012 May;124(9-10):293-303
pubmed: 22538839
NPJ Prim Care Respir Med. 2014 Jun 26;24:14020
pubmed: 24964767
J Asthma. 2018 Feb;55(2):119-123
pubmed: 28471703
N Engl J Med. 2017 Oct 5;377(14):1309-1312
pubmed: 28976860
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
Clin Mol Allergy. 2016 Sep 28;14:12
pubmed: 27708552
Allergy. 2010 Aug;65(8):959-68
pubmed: 20486919
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
Allergy. 2012 Nov;67(11):1443-50
pubmed: 22978345
J Asthma. 2004 Feb;41(1):117-26
pubmed: 15046386
Pulmonology. 2020 Mar - Apr;26(2):73-77
pubmed: 30737172
BMC Health Serv Res. 2013 Jun 11;13:211
pubmed: 23758898
Value Health. 2007 Nov-Dec;10 Suppl 2:S94-S105
pubmed: 17995479
J Allergy Clin Immunol. 2014 Jan;133(1):27-33
pubmed: 24369796
J Asthma. 2011 Feb;48(1):41-7
pubmed: 21050027
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
Allergy. 2011 Apr;66(4):439-57
pubmed: 21058958
Clin Otolaryngol. 2017 Apr;42(2):218-224
pubmed: 27385478
Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37
pubmed: 17995471
Lancet. 2008 Sep 20;372(9643):1049-57
pubmed: 18805333
Immunol Allergy Clin North Am. 2016 May;36(2):235-48
pubmed: 27083099

Auteurs

Maciej Kupczyk (M)

Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.

Ilaria Baiardini (I)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Giorgia Molinengo (G)

Department of Psychology, University of Turin, Turin, Italy.

Barbara Loera (B)

Department of Psychology, University of Turin, Turin, Italy.

Dorota Szydłowska (D)

Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.

Piotr Kuna (P)

Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.

Giorgio Walter Canonica (GW)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Personalized Medicine, Asthma and Allergy Clinic, Humanitas Research Hospital, Milan, Italy.

Fulvio Braido (F)

IRCCS Ospedale Policlinico San Martino, Università di Genova, Dipartimento di Medicina Interna (DiMI), Genova, Italy.

Classifications MeSH